April 15, 2026Medical DevicesFDA
Medline Industries, LP recalls Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringe
Hazard: Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
April 15, 2026Medical DevicesFDA
Medline Industries, LP recalls Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringe
Hazard: Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
April 15, 2026Medical DevicesFDA
Medline Industries, LP recalls Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringe
Hazard: Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
April 15, 2026Medical DevicesFDA
Medline Industries, LP recalls Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringe
Hazard: Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
April 15, 2026Medical DevicesFDA
Medline Industries, LP recalls NAMIC Angiographic Syringe, labeled as follows: 1. SYRINGE,20ML,CONTROL,-,PKG, Medline SKU 70075027; 2. SYRINGE,10ML,TR/
Hazard: Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
April 15, 2026Medical DevicesFDA
Medline Industries, LP recalls NAMIC Angiographic Syringe, labeled as follows: 1. SYRINGE,20ML,CONTROL,-,PKG, Medline SKU 70075027; 2. SYRINGE,10ML,TR/
Hazard: Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
April 15, 2026Medical DevicesFDA
Medline Industries, LP recalls Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringe
Hazard: Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
April 15, 2026Medical DevicesFDA
Medline Industries, LP recalls Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringe
Hazard: Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
April 15, 2026Medical DevicesFDA
Medline Industries, LP recalls Medline medical convenience kits, containing NAMIC Angiographic Rotating Adaptor (RA) Control Syringes (Namic RA syringe
Hazard: Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
April 15, 2026Medical DevicesFDA
Medline Industries, LP recalls NAMIC Angiographic Control Syringe, labeled as follows: 1. SYRINGE,7ML,TR/FR,RA,W/RES,-,P/G, Medline SKU 70083007;
Hazard: Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
April 15, 2026Medical DevicesFDA
Medline Industries, LP recalls NAMIC Angiographic Syringe, labeled as follows: 1. SYRINGE,20ML,CONTROL,-,PKG, Medline SKU 70075027; 2. SYRINGE,10M
Hazard: Medline Industries, LP has identified through post-market surveillance a potential risk of the syringe rotating adaptor unwinding during use, which may result in a loose connection and/or full disconnection between the syringe and manifold.
April 15, 2026Medical DevicesFDA
Siemens Medical Solutions USA, Inc recalls ARTIS pheno and ARTIS Icono biplane, floor and ceiling. Model Numbers 10849000, 11327600, 11328100, 11327700.
Hazard: During patient examinations, the system may sporadically display a major increase of the x-ray dose applied to the patient. Despite the reported dose showing significantly higher, the actual applied x-ray dose levels are in accordance with the system settings and imaging conditions, as well as the applicable regulatory requirements.
April 8, 2026Medical DevicesFDA
Cardinal Health 200, LLC recalls Cardinal Health Monoject Tuberculin Syringe, 1 mL Luer Lock, Catalog Number 1180100777
Hazard: The outer packaging and blister pack labeling identify the product as 1mL Luer Lock Tuberculin Syringe (Product Code 1180100777), however the syringes contained within the packages are U-100 Insulin syringes.
April 8, 2026Medical DevicesFDA
GE Healthcare LLC recalls SIGNA Premier systems
Hazard: Whole-Body MR scanners used to produce images of the inside of the human body to aid diagnosis of disease may have been manufactured/serviced with ferrous (steel) fittings instead of non-ferrous (brass) fittings on the magnet rear and if system is accessed to perform service while the magnet is ramped, the magnetic field could attract the ferrous fittings potentially resulting in personnel injury.
April 8, 2026Medical DevicesFDA
Oxoid Australia Pty Limited recalls OXOID MICROBACT IDENTIFICATION KITS, Listeria 12L Kit, 20 Tests; Listeria identification sysystem
Hazard: Oxoid Ltd., part of Thermo Fisher Scientific, confirmed that Microbact 12L Kit 20 Tests MB1128A lot 4494873 may identify incorrect organism due to inconclusive result from ambiguous color reactions in wells.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Kilt Blockers.
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Blockers.
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Demi Half Aprons.
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Half Aprons.
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Leg Wraps.
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Caps.
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Protective Sleeves.
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, BAT (Breast, Axilla and Thyroid) Coverage.
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Wrap Aprons.
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Frontal Aprons
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Kilt
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Vest
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Burlington Medical, LLC recalls Burlington Medical, Thyroid Shield.
Hazard: Potential for attenuation degradation over time, decreasing the lifespan.
April 8, 2026Medical DevicesFDA
Medtronic MiniMed, Inc. recalls Paradigm REAL-Time Veo Insulin Pump (MMT-554, MMT-754)
Hazard: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.
April 8, 2026Medical DevicesFDA
Medtronic MiniMed, Inc. recalls MiniMed 530G Insulin Pump (MMT-551, MMT-751)
Hazard: All Medtronic MiniMed infusion pumps (Paradigm series, 600 series, and BLE 700 series) were found to be affected by unintended over- and under-delivery of insulin when the pump is elevated or lowered relative to the infusion site, respectively, because of changes in gravitational force impacting hydrostatic and hydrodynamic pressures. Insulin over-delivery, which can occur when the pump is elevated relative to the infusion site, can result in severe hypoglycemia, altered mental status, seizure, coma, or death. An under-delivery of insulin, which can occur at lowered pump height conditions relative to the infusion site, can result in severe hyperglycemia, dehydration, diabetic ketoacidosis, or death.